Results from a randomized controlled trial comparing two low-calorie diet formulae

Obesity Research & Clinical Practice
M Neovius, S Rössner

Abstract

Very low and low-calorie diets ((V)LCD) are commonly used in the early phase of obesity treatment programmes. Recently, a new formula, Allévo(®), was introduced in Scandinavia. No study has hitherto assessed its efficacy compared to the commonly used (V)LCD Nutrilett(®). To compare Allévo(®) with Nutrilett(®) regarding short-term effects on weight and BMI loss, ketonaemia, compliance, and body composition. Thirty-six males (baseline: age 46.5 ± 10.9 year; BMI 39.2 ± 3.8 kg/m(2); %BF 38.8 ± 3.9%) participated in a randomized trial comparing two LCDs, differing mainly in protein and dietary fibre composition. Body composition was measured by DXA at baseline and end, while body weight was measured weekly during the 8-week (V) LCD-intervention. The main outcome measures were weight, BMI, waist-circumference (WC), and body fat percentage (%BF). No significant differences between groups in age, weight, blood pressure, or %BF were observed at baseline (all p > 0.3). The mean BMI change over the study period was -4.4 ± 0.3 and -4.2 ± 1.9 kg/m(2) for Nutrilett(®) and Allévo(®), respectively (p = 0.72), while WC was reduced by 9.6 ± 1.0 and 10.1 ± 3.2 cm, respectively (p = 0.51). About 49% of the weight loss consisted of fat. When examin...Continue Reading

References

Mar 1, 1995·Scandinavian Journal of Primary Health Care·L H Høie, D Bruusgaard
Dec 1, 1993·The Clinical Investigator·M J Müller, R Grossklaus
Jan 1, 1997·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·S Rössner, H Flaten
Nov 22, 1997·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·J S TorgersonL Sjöström
Mar 21, 1998·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·S Rössner
Mar 17, 1999·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·J S TorgersonL Sjöström
May 29, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·Y LinnéS Rössner
Jan 16, 2003·Patient Education and Counseling·Ingela Melin, Stephan Rössner
Oct 4, 2003·Current Atherosclerosis Reports·Eric C WestmanJeff S Volek

❮ Previous
Next ❯

Citations

Mar 15, 2016·Iranian Journal of Psychiatry and Behavioral Sciences·Fatemeh AbdollahiMunn-Sann Lye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

© 2021 Meta ULC. All rights reserved